You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
尚榮醫療(002551.SZ):2021年度淨利潤預降62.99%-75.33%
格隆匯 02-04 21:36

格隆匯2月4日丨尚榮醫療(002551.SZ)公佈,預計2021年度歸屬於上市公司股東的淨利潤4000萬元-6000萬元,同比下降62.99%-75.33%;扣除非經常性損益後的淨利潤1117.47萬元-3117.47萬元,同比下降79.73%-92.74%。

業績變動原因:1、報吿期內,公司控股子公司合肥普爾德醫療用品有限公司(普爾德醫療)普爾德控股有限公司(“普爾德控股”)的主要產品為一次性醫用防護產品和一次性醫用耗材產品由於國際運輸緊張導致的訂單出貨困難嚴重影響了公司產品銷量,運輸成本增加,且出不了貨導致產品價格有所調整,致使本報吿期普爾德醫療和普爾德控股的淨利潤同比出現了大幅下降。

2、由於部分區域疫情的持續影響,公司醫療專業工程項目的進度不達預期導致工程不能按時完工結算各項成本增加,致使本報吿期醫療專業工程項目的淨利潤大幅下降

3、根據《企業會計準則第8-資產減值》及相關會計政策規定,結合公司的實際經營情況及公司各項資產的運行與財務狀況,基於謹慎性原則,公司對報吿期內出現減值(跌價)跡象的相關資產進行初步減值測試,預計需計提資產減值(跌價)準備金額約3000萬元-4000萬元(最終數據以審計報吿為準)

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account